LONG LASTING DRUG FORMULATIONS

The present invention is directed to long-lasting erythropoietin therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PEARLMAN, ANDREW, L, STERN, BARUCH, S
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	AGRICULTURE ANIMAL HUSBANDRY BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES FISHING FORESTRY HUMAN NECESSITIES HUNTING HYGIENE MEDICAL OR VETERINARY SCIENCE PEST REPELLANTS OR ATTRACTANTS PLANT GROWTH REGULATORS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF TRAPPING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	PEARLMAN, ANDREW, L STERN, BARUCH, S
description	The present invention is directed to long-lasting erythropoietin therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes erythropoietin. La présente invention concerne des formulations thérapeutiques de longue durée d'érythropoïétine et leurs procédés d'utilisation. Selon l'invention, la formulation comprend un micro-organe génétiquement modifié qui comprend un vecteur comprenant une séquence d'acide nucléique liée de façon fonctionnelle à une ou plusieurs séquences régulatrices, la séquence d'acide nucléique codant pour l'érythropoïétine.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2013069016A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2013069016A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2013069016A33</originalsourceid><addsrcrecordid>eNrjZJDz8fdzV_BxDA7xBNIuQaHuCm7-Qb6hPo4hnv5-wTwMrGmJOcWpvFCam0HZzTXE2UM3tSA_PrW4IDE5NS-1JD7c38jA0NjAzNLA0MzR2Jg4VQBFuiJo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LONG LASTING DRUG FORMULATIONS</title><source>esp@cenet</source><creator>PEARLMAN, ANDREW, L ; STERN, BARUCH, S</creator><creatorcontrib>PEARLMAN, ANDREW, L ; STERN, BARUCH, S</creatorcontrib><description>The present invention is directed to long-lasting erythropoietin therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes erythropoietin. La présente invention concerne des formulations thérapeutiques de longue durée d'érythropoïétine et leurs procédés d'utilisation. Selon l'invention, la formulation comprend un micro-organe génétiquement modifié qui comprend un vecteur comprenant une séquence d'acide nucléique liée de façon fonctionnelle à une ou plusieurs séquences régulatrices, la séquence d'acide nucléique codant pour l'érythropoïétine.</description><language>eng ; fre</language><subject>AGRICULTURE ; ANIMAL HUSBANDRY ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES ; FISHING ; FORESTRY ; HUMAN NECESSITIES ; HUNTING ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PEST REPELLANTS OR ATTRACTANTS ; PLANT GROWTH REGULATORS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF ; TRAPPING</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130718&DB=EPODOC&CC=WO&NR=2013069016A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130718&DB=EPODOC&CC=WO&NR=2013069016A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PEARLMAN, ANDREW, L</creatorcontrib><creatorcontrib>STERN, BARUCH, S</creatorcontrib><title>LONG LASTING DRUG FORMULATIONS</title><description>The present invention is directed to long-lasting erythropoietin therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes erythropoietin. La présente invention concerne des formulations thérapeutiques de longue durée d'érythropoïétine et leurs procédés d'utilisation. Selon l'invention, la formulation comprend un micro-organe génétiquement modifié qui comprend un vecteur comprenant une séquence d'acide nucléique liée de façon fonctionnelle à une ou plusieurs séquences régulatrices, la séquence d'acide nucléique codant pour l'érythropoïétine.</description><subject>AGRICULTURE</subject><subject>ANIMAL HUSBANDRY</subject><subject>BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES</subject><subject>FISHING</subject><subject>FORESTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HUNTING</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PEST REPELLANTS OR ATTRACTANTS</subject><subject>PLANT GROWTH REGULATORS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF</subject><subject>TRAPPING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDz8fdzV_BxDA7xBNIuQaHuCm7-Qb6hPo4hnv5-wTwMrGmJOcWpvFCam0HZzTXE2UM3tSA_PrW4IDE5NS-1JD7c38jA0NjAzNLA0MzR2Jg4VQBFuiJo</recordid><startdate>20130718</startdate><enddate>20130718</enddate><creator>PEARLMAN, ANDREW, L</creator><creator>STERN, BARUCH, S</creator><scope>EVB</scope></search><sort><creationdate>20130718</creationdate><title>LONG LASTING DRUG FORMULATIONS</title><author>PEARLMAN, ANDREW, L ; STERN, BARUCH, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2013069016A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2013</creationdate><topic>AGRICULTURE</topic><topic>ANIMAL HUSBANDRY</topic><topic>BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES</topic><topic>FISHING</topic><topic>FORESTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HUNTING</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PEST REPELLANTS OR ATTRACTANTS</topic><topic>PLANT GROWTH REGULATORS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF</topic><topic>TRAPPING</topic><toplevel>online_resources</toplevel><creatorcontrib>PEARLMAN, ANDREW, L</creatorcontrib><creatorcontrib>STERN, BARUCH, S</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PEARLMAN, ANDREW, L</au><au>STERN, BARUCH, S</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LONG LASTING DRUG FORMULATIONS</title><date>2013-07-18</date><risdate>2013</risdate><abstract>The present invention is directed to long-lasting erythropoietin therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes erythropoietin. La présente invention concerne des formulations thérapeutiques de longue durée d'érythropoïétine et leurs procédés d'utilisation. Selon l'invention, la formulation comprend un micro-organe génétiquement modifié qui comprend un vecteur comprenant une séquence d'acide nucléique liée de façon fonctionnelle à une ou plusieurs séquences régulatrices, la séquence d'acide nucléique codant pour l'érythropoïétine.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre
recordid	cdi_epo_espacenet_WO2013069016A3
source	esp@cenet
subjects	AGRICULTURE ANIMAL HUSBANDRY BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES FISHING FORESTRY HUMAN NECESSITIES HUNTING HYGIENE MEDICAL OR VETERINARY SCIENCE PEST REPELLANTS OR ATTRACTANTS PLANT GROWTH REGULATORS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF TRAPPING
title	LONG LASTING DRUG FORMULATIONS
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T23%3A15%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PEARLMAN,%20ANDREW,%20L&rft.date=2013-07-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2013069016A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true